View in EDS HTML Full Text PDF Full Text

C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma.

Saved in:
Bibliographic Details
Title: C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma.
Authors: Pang C; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.; Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, Hebei, People's Republic of China., Chen J; Digestive System Department, Affiliated Hospital of Chengde Medical University, Chengde Medical University, Chengde, Hebei, People's Republic of China., Chu M; Institute of Sericulture, Chengde Medical University, Chengde, Hebei, People's Republic of China., Chen J; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China., Wang H; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China., Miao H; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.
Source: Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2026 Apr 13; Vol. 13, pp. 587037. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Country of Publication: New Zealand NLM ID: 101674775 Publication Model: eCollection Cited Medium: Print ISSN: 2253-5969 (Print) Linking ISSN: 22535969 NLM ISO Abbreviation: J Hepatocell Carcinoma Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42003875
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pang+C%22">Pang C</searchLink>; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.; Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, Hebei, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Digestive System Department, Affiliated Hospital of Chengde Medical University, Chengde Medical University, Chengde, Hebei, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Chu+M%22">Chu M</searchLink>; Institute of Sericulture, Chengde Medical University, Chengde, Hebei, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Miao+H%22">Miao H</searchLink>; Functional Experiment Center, School of Basic Medicine Sciences, Chengde Medical University, Chengde, Hebei, People's Republic of China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674775%22">Journal of hepatocellular carcinoma</searchLink> [J Hepatocell Carcinoma] 2026 Apr 13; Vol. 13, pp. 587037. <i>Date of Electronic Publication: </i>2026 Apr 13 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press%22">Dove Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101674775 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2253-5969 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222535969%22">22535969 </searchLink><i>NLM ISO Abbreviation: </i>J Hepatocell Carcinoma <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42003875
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/JHC.S587037
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 587037
    Titles:
      – TitleFull: C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pang C
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Chu M
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Miao H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 04
              Text: 2026 Apr 13
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2253-5969
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Journal of hepatocellular carcinoma
              Type: main
ResultId 1